N6-methyladenosine modification of FAM120A enhanced cisplatin resistance by inhibiting ferroptosis and targeting FAM120A is an effective strategy to alleviate cisplatin resistance in gastric cancer. This evidence concerns the gene FAM120A and gastric cancer.